| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine, University of Chicago Hospitals and Clinics, Pritzker School of Medicine, University of Chicago, Chicago, Illinois 60637
Recently, a number of studies in experimental animals and humans have suggested that alterations in the activity of protein kinase C (PKC) may be involved in the malignant transformation process. To determine whether such alterations in this kinase were present before the development of 1,2-dimethylhydrazine (DMH)-induced colon cancers, rats were given s.c. injections of this procarcinogen (20 mg/kg body weight/week) or diluent for 10 or 15 weeks. Animals were sacrificed after these time periods and colonic epithelium was harvested from each group. The activity and distribution of PKC in the cytosolic and membrane fractions of these preparations as well as 1,2-diacylglycerol mass and phosphoinositide turnover were then examined and compared in the presence and absence of 10 nM 1,25-dihydroxycholecalciferol, an agent which has previously been found to influence these biochemical parameters in the normal rat colonic epithelium.
The results of these studies demonstrate that: (a) the percentage of PKC activity in the membrane fraction was significantly greater in DMH-treated animals compared to their control counterparts at 10 and 15 weeks; (b) the total PKC activity was similar at 10 weeks, but markedly reduced in the colonic mucosa of the DMH-treated group at 15 weeks; (c) 1,2-diacylglycerol mass and phosphoinositide turnover were increased in the colonic mucosa of rats administered this carcinogen at both time points; and (d) in control, but not in DMH-treated animals, in vitro addition of 1,25-dihydroxycholecalciferol increased PKC activity, 1,2-diacylglycerol mass and phosphoinositide turnover at each of the times studied. Based on these findings, it would appear that alterations in PKC activity may play a role in the malignant transformation process of the colon in animals administered DMH.
1 These experiments were supported by the Samuel Freedman Laboratories for Cancer Research Fund as well as by USPHS Grant CA 36745 awarded by the National Cancer Institute, by USPHS Grant DK 26678 (Clinical Nutrition Research Unit) awarded by the National Institute of Diabetes and Digestive and Kidney Diseases, Department of Health and Human Services, and by USPHS Grant DK 39573 by the National Institute of Diabetes and Digestive and Kidney Diseases, Department of Health and Human Services.
2 Recipient of a MERIT award from the National Cancer Institute, NIH. To whom requests for reprints should be addressed, at University of Chicago Hospitals and Clinics, 5841 S. Maryland Avenue, Box 400, Chicago, IL 60637.
Received 11/17/89.
Revised 3/13/90.
This article has been cited by other articles:
![]() |
Y. Liu, W. Su, E. A. Thompson, M. Leitges, N. R. Murray, and A. P. Fields Protein Kinase C{beta}II Regulates Its Own Expression in Rat Intestinal Epithelial Cells and the Colonic Epithelium in Vivo J. Biol. Chem., October 29, 2004; 279(44): 45556 - 45563. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, P. Z. Anastasiadis, Y. Liu, E. A. Thompson, and A. P. Fields Protein Kinase C (PKC) {beta}II Induces Cell Invasion through a Ras/Mek-, PKC{iota}/Rac 1-dependent Signaling Pathway J. Biol. Chem., May 21, 2004; 279(21): 22118 - 22123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Parker, R. N. O'Meally, F. Sahin, G. H. Su, F. K. Racke, W. G. Nelson, T. L. DeWeese, and J. R. Eshleman Defective Human MutY Phosphorylation Exists in Colorectal Cancer Cell Lines with Wild-type MutY Alleles J. Biol. Chem., November 28, 2003; 278(48): 47937 - 47945. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Davis and W. T. Johnson Dietary Copper Affects Azoxymethane-Induced Intestinal Tumor Formation and Protein Kinase C Isozyme Protein and mRNA Expression in Colon of Rats J. Nutr., May 1, 2002; 132(5): 1018 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bissonnette, S. Khare, F. C. von Lintig, R. K. Wali, L. Nguyen, Y. Zhang, J. Hart, S. Skarosi, N. Varki, G. R. Boss, et al. Mutational and Nonmutational Activation of p21ras in Rat Colonic Azoxymethane-induced Tumors: Effects on Mitogen-activated Protein Kinase, Cyclooxygenase-2, and Cyclin D1 Cancer Res., August 1, 2000; 60(16): 4602 - 4609. [Abstract] [Full Text] |
||||
![]() |
S. Umar, J. H. Sellin, and A. P. Morris Increased nuclear translocation of catalytically active PKC-zeta during mouse colonocyte hyperproliferation Am J Physiol Gastrointest Liver Physiol, July 1, 2000; 279(1): G223 - G237. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Batlle, J. Verdu, D. Dominguez, M. d. M. Llosas, V. Diaz, N. Loukili, R. Paciucci, F. Alameda, and A. G. de Herreros Protein Kinase C-alpha Activity Inversely Modulates Invasion and Growth of Intestinal Cells J. Biol. Chem., June 12, 1998; 273(24): 15091 - 15098. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Jiang, J. R. Lupton, and R. S. Chapkin Dietary Fat and Fiber Modulate the Effect of Carcinogen on Colonic Protein Kinase C lambda Expression in Rats J. Nutr., October 1, 1997; 127(10): 1938 - 1943. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |